Lumos Diagnostics Holdings Limited LDXHF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.05% | 16.05% | -2.95% | -2.95% | -27.15% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.05% | 16.05% | -2.95% | -2.95% | -27.15% |
| Cost of Revenue | 26.19% | 26.19% | -4.84% | -4.84% | -20.18% |
| Gross Profit | 8.23% | 8.23% | -2.03% | -2.03% | -31.75% |
| SG&A Expenses | 44.74% | 44.74% | 45.43% | 45.43% | 19.91% |
| Depreciation & Amortization | 7.60% | 7.60% | -5.36% | -5.36% | -12.62% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.37% | 37.37% | 29.22% | 29.22% | 2.92% |
| Operating Income | -65.62% | -65.62% | -87.72% | -87.72% | -126.99% |
| Income Before Tax | 98.36% | 98.36% | -74.04% | -74.04% | -100.96% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 98.36% | 98.36% | -74.04% | -74.04% | -100.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 98.36% | 98.36% | -74.04% | -74.04% | -100.96% |
| EBIT | -65.62% | -65.62% | -87.72% | -87.72% | -126.99% |
| EBITDA | -70.68% | -77.34% | -146.61% | -146.61% | -155.13% |
| EPS Basic | 100.00% | 100.00% | -39.13% | -39.13% | -26.09% |
| Normalized Basic EPS | -27.78% | -27.78% | -42.86% | -42.86% | -28.57% |
| EPS Diluted | 96.55% | 96.55% | -39.13% | -39.13% | -26.09% |
| Normalized Diluted EPS | -27.78% | -27.78% | -42.86% | -42.86% | -28.57% |
| Average Basic Shares Outstanding | 14.32% | 14.32% | 26.02% | 26.02% | 55.08% |
| Average Diluted Shares Outstanding | 14.32% | 14.32% | 26.02% | 26.02% | 55.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |